A
516.18
0.31 (0.06%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bearish |
| Biotechnology (Global) | Mixed | Bearish | |
| Stock | argenx SE | Bullish | Bearish |
Stockmoo Score
1.1
|
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Mid Growth |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 640.00 (JP Morgan, 23.99%) | Buy |
| Median | 543.50 (5.29%) | |
| Low | 500.00 (Stifel, -3.14%) | Buy |
| Average | 554.58 (7.44%) | |
| Total | 12 Buy | |
| Avg. Price @ Call | 478.10 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 23 Aug 2024 | 640.00 (23.99%) | Buy | 516.69 |
| Baird | 29 Jul 2024 | 515.00 (-0.23%) | Buy | 499.05 |
| Guggenheim | 26 Jul 2024 | 585.00 (13.33%) | Buy | 494.46 |
| HC Wainwright & Co. | 26 Jul 2024 | 533.00 (3.26%) | Buy | 494.46 |
| 17 Jul 2024 | 504.00 (-2.36%) | Buy | 463.41 | |
| Oppenheimer | 26 Jul 2024 | 560.00 (8.49%) | Buy | 494.46 |
| 23 Jul 2024 | 546.00 (5.78%) | Buy | 472.87 | |
| Wedbush | 26 Jul 2024 | 560.00 (8.49%) | Buy | 494.46 |
| 22 Jul 2024 | 519.00 (0.55%) | Buy | 461.01 | |
| Wells Fargo | 26 Jul 2024 | 547.00 (5.97%) | Buy | 494.46 |
| 24 Jun 2024 | 542.00 (5.00%) | Buy | 440.59 | |
| Truist Securities | 22 Jul 2024 | 540.00 (4.61%) | Buy | 461.01 |
| 25 Jun 2024 | 480.00 (-7.01%) | Buy | 451.55 | |
| Evercore ISI Group | 12 Jul 2024 | 533.00 (3.26%) | Buy | 466.42 |
| B of A Securities | 24 Jun 2024 | 607.00 (17.59%) | Buy | 440.59 |
| Piper Sandler | 24 Jun 2024 | 535.00 (3.65%) | Buy | 440.59 |
| 17 Jun 2024 | 522.00 (1.13%) | Buy | 378.30 | |
| Stifel | 24 Jun 2024 | 500.00 (-3.13%) | Buy | 440.59 |
| Show more | ||||
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |